Please note: Work is currently underway to update content available on this site.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Director Letters (formerly MELs/CELs/HDLs etc) are currently being reviewed to ensure it is clear which publications are current, superseded or obsolete.
Publication #7378
Reference
MSAN(2021)29
Name
Kolanticon gel® (2.5mg dicycloverine hydrochloride, 200mg aluminium hydroxide, 100mg light magnesium oxide, 20mg simethicone per 5ml)
Categories
Scottish Government
Drug Alerts
Organization
Scottish Government Health and Social Care Directorates
Keywords
NHS
SCOTLAND
DRUGS
SAFETY
RISKS
PHARMACEUTICAL INDUSTRY
DRUG THERAPY
PHARMACEUTICAL SERVICES
SUPPLIES
Description
1. Kolanticon gel® is out of stock until January 2022.
2. Alternative preparations for symptomatic relief of gastro-intestinal disorders characterised by hyperacidity, smooth muscle spasm, including irritable bowel syndrome (IBS), and flatulence, remain available.
2. Alternative preparations for symptomatic relief of gastro-intestinal disorders characterised by hyperacidity, smooth muscle spasm, including irritable bowel syndrome (IBS), and flatulence, remain available.
Contact Name
Contact Email
Contact Address
Created
2021-08-06 00:00:00
Click to go back to homepage